Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Operating Leases (2019 - 2025)

Historic Operating Leases for Option Care Health (OPCH) over the last 7 years, with Q3 2025 value amounting to $114.4 million.

  • Option Care Health's Operating Leases rose 407.4% to $114.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.4 million, marking a year-over-year increase of 407.4%. This contributed to the annual value of $84.8 million for FY2024, which is 82.82% down from last year.
  • According to the latest figures from Q3 2025, Option Care Health's Operating Leases is $114.4 million, which was up 407.4% from $118.5 million recorded in Q2 2025.
  • Option Care Health's Operating Leases' 5-year high stood at $118.5 million during Q2 2025, with a 5-year trough of $71.4 million in Q4 2022.
  • Its 5-year average for Operating Leases is $96.3 million, with a median of $92.3 million in 2022.
  • Its Operating Leases has fluctuated over the past 5 years, first surged by 2726.17% in 2021, then plummeted by 569.2% in 2023.
  • Over the past 5 years, Option Care Health's Operating Leases (Quarter) stood at $74.5 million in 2021, then dropped by 4.1% to $71.4 million in 2022, then grew by 19.66% to $85.5 million in 2023, then fell by 0.83% to $84.8 million in 2024, then surged by 34.91% to $114.4 million in 2025.
  • Its Operating Leases was $114.4 million in Q3 2025, compared to $118.5 million in Q2 2025 and $112.3 million in Q1 2025.